chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Injection site swelling, Lymphadenopathy, Myalgia, Pyrexia
Clinical narrative: Chills/fever at bedtime followed by swelling around injection site and under left arm pit with muscle soreness and soft tissue lump under left arm pit from Monday night 11/30 thru Thurs 12/02 soreness still present with lump. Treatment: 2x daily rubbing w alcohol with epsom salt solution and massage 3x daily Reported to health department nurse today by phone 12/02/2021. She stated it may be related to immune system lymph nodes swelling but should improve in next few days.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Exposure to SARS-CoV-2, Fatigue
Clinical narrative: The patient reports headache, chills, congestion, cough, fatigue, nausea, and sore throat starting Monday 11/29. The patient received her Pfizer booster on 11/23. The patient's daughter is confirmed positive COVID-19 and she had exposure to her daughter. The patient tested positive for COVID-19 during encounter. The patient was discharged home in stable condition.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Influenza A virus test negative, Influenza B virus test, Influenza virus test negative, Nausea
Clinical narrative: The patient reports headache, chills, congestion, cough, fatigue, nausea, and sore throat starting Monday 11/29. The patient received her Pfizer booster on 11/23. The patient's daughter is confirmed positive COVID-19 and she had exposure to her daughter. The patient tested positive for COVID-19 during encounter. The patient was discharged home in stable condition.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: The patient reports headache, chills, congestion, cough, fatigue, nausea, and sore throat starting Monday 11/29. The patient received her Pfizer booster on 11/23. The patient's daughter is confirmed positive COVID-19 and she had exposure to her daughter. The patient tested positive for COVID-19 during encounter. The patient was discharged home in stable condition.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension
Clinical narrative: I had high blood pressure.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling hot, Genital erythema, Manipulation, Testicular pain, Testicular swelling
Clinical narrative: Approximately one week after administration of the vaccination I started having severe pain in my testicles. This included swelling, redness, heat and pain. The pain was severe. These symptoms were constant for about 2 months. The symptoms are no longer constant but, they are intermittent now. It will return for several days and then subside only to return again. The pain is about a 7-8 out of 10. I have surgery scheduled for 12/13/2021. I have a varicocele since childhood that has never given me any pain. They are going to repair it in an effort to stop this pain.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Ultrasound testes abnormal
Clinical narrative: Approximately one week after administration of the vaccination I started having severe pain in my testicles. This included swelling, redness, heat and pain. The pain was severe. These symptoms were constant for about 2 months. The symptoms are no longer constant but, they are intermittent now. It will return for several days and then subside only to return again. The pain is about a 7-8 out of 10. I have surgery scheduled for 12/13/2021. I have a varicocele since childhood that has never given me any pain. They are going to repair it in an effort to stop this pain.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Blood urine present, Chills, Computerised tomogram, Cystoscopy
Clinical narrative: On 10/20/2021, I went for my Pzifer booster shot as instructed by my doctors.  I had a fever for five days, extreme chills and shaking of my body.  The blood in my urine appeared on 10/22/2021. I immediately contacted my primary care physician, who tested my urine and did blood work to test my kidney function.   I had gross hematuria and proteinuria found in my urine.  Due to my history of both cancer and auto immune issues, my PCP sent me to a nephrologist and urologist.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Cytology, Extra dose administered, Haematuria, Proteinuria, Pyrexia
Clinical narrative: On 10/20/2021, I went for my Pzifer booster shot as instructed by my doctors.  I had a fever for five days, extreme chills and shaking of my body.  The blood in my urine appeared on 10/22/2021. I immediately contacted my primary care physician, who tested my urine and did blood work to test my kidney function.   I had gross hematuria and proteinuria found in my urine.  Due to my history of both cancer and auto immune issues, my PCP sent me to a nephrologist and urologist.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Renal function test, Tremor, Ultrasound bladder, Ultrasound kidney, Urine analysis
Clinical narrative: On 10/20/2021, I went for my Pzifer booster shot as instructed by my doctors.  I had a fever for five days, extreme chills and shaking of my body.  The blood in my urine appeared on 10/22/2021. I immediately contacted my primary care physician, who tested my urine and did blood work to test my kidney function.   I had gross hematuria and proteinuria found in my urine.  Due to my history of both cancer and auto immune issues, my PCP sent me to a nephrologist and urologist.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Underdose
Clinical narrative: No adverse effects. Child was given pediatric dose of second vaccine. She turned 12 one week before the vaccine. Parent scheduled appt for pediatric dose.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Incorrect Dose Moderna booster dose administered was 0.5 milliliters. Booster dose should have been 0.25 milliliters.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Bone pain, Bone swelling, Condition aggravated, Injection site erythema
Clinical narrative: Swelling, pain, redness, and heat. Started at injection site, but has spread to whole shoulder and collar bone area.   Ibuprofen helps with the pain and stiffness, but not the swelling.  I have not seen a doctor, but want to report my reaction. I will see a doctor if it does not start getting better.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Injection site swelling, Injection site warmth, Joint swelling, Musculoskeletal stiffness
Clinical narrative: Swelling, pain, redness, and heat. Started at injection site, but has spread to whole shoulder and collar bone area.   Ibuprofen helps with the pain and stiffness, but not the swelling.  I have not seen a doctor, but want to report my reaction. I will see a doctor if it does not start getting better.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Swelling
Clinical narrative: Swelling, pain, redness, and heat. Started at injection site, but has spread to whole shoulder and collar bone area.   Ibuprofen helps with the pain and stiffness, but not the swelling.  I have not seen a doctor, but want to report my reaction. I will see a doctor if it does not start getting better.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Brain natriuretic peptide normal, COVID-19, Chest X-ray abnormal, Cough, Decreased appetite
Clinical narrative: This is a 76y.o. female with obesity, sleep apnea, type 2 diabetes, paroxysmal atrial fibrillation, hypertension, hypothyroidism, tachy-brady syndrome with pacemaker, and chronic diastolic heart failure who presents with shortness of breath x 2 days. She feels it's been getting progressively worse. She also has bilateral lower extremity swelling. She also complains of dry cough, decreased appetite, and occasional nausea. No fever, chills, known exposures, or chest pain. Last 2-D echocardiogram in 2019 showed EF 60% and HFpEF.   Upon arrival to the ED, SpO2 was 89% on room air and 2 liters of supplemental oxygen applied. Chest x-ray concerning for CHF. BNP 51, D-dimer 458, troponin negative, procalcitonin 0.32. COVID-19 detected. The patient was admitted for further evaluation and management.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fibrin D dimer, Nausea, Peripheral swelling, Procalcitonin increased
Clinical narrative: This is a 76y.o. female with obesity, sleep apnea, type 2 diabetes, paroxysmal atrial fibrillation, hypertension, hypothyroidism, tachy-brady syndrome with pacemaker, and chronic diastolic heart failure who presents with shortness of breath x 2 days. She feels it's been getting progressively worse. She also has bilateral lower extremity swelling. She also complains of dry cough, decreased appetite, and occasional nausea. No fever, chills, known exposures, or chest pain. Last 2-D echocardiogram in 2019 showed EF 60% and HFpEF.   Upon arrival to the ED, SpO2 was 89% on room air and 2 liters of supplemental oxygen applied. Chest x-ray concerning for CHF. BNP 51, D-dimer 458, troponin negative, procalcitonin 0.32. COVID-19 detected. The patient was admitted for further evaluation and management.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Troponin normal
Clinical narrative: This is a 76y.o. female with obesity, sleep apnea, type 2 diabetes, paroxysmal atrial fibrillation, hypertension, hypothyroidism, tachy-brady syndrome with pacemaker, and chronic diastolic heart failure who presents with shortness of breath x 2 days. She feels it's been getting progressively worse. She also has bilateral lower extremity swelling. She also complains of dry cough, decreased appetite, and occasional nausea. No fever, chills, known exposures, or chest pain. Last 2-D echocardiogram in 2019 showed EF 60% and HFpEF.   Upon arrival to the ED, SpO2 was 89% on room air and 2 liters of supplemental oxygen applied. Chest x-ray concerning for CHF. BNP 51, D-dimer 458, troponin negative, procalcitonin 0.32. COVID-19 detected. The patient was admitted for further evaluation and management.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Electric shock sensation, Pain
Clinical narrative: Feeling of electrical currents going thru body sever pain
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Influenza, Pain, Parosmia
Clinical narrative: Flu symptoms for 2 days after. Slight fever, body aches, fatigue, and diarrhea.  2-3 weeks after vaccination (approx 11/2/2021) a phantom smell started (patient smells it but it is not real). The smell comes and goes and varies in strength. Smells like rotting food / sewer. This is on going as of 12/2/2021 and is not improving.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Flu symptoms for 2 days after. Slight fever, body aches, fatigue, and diarrhea.  2-3 weeks after vaccination (approx 11/2/2021) a phantom smell started (patient smells it but it is not real). The smell comes and goes and varies in strength. Smells like rotting food / sewer. This is on going as of 12/2/2021 and is not improving.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Diarrhoea, Fatigue, Headache, Injection site pruritus
Clinical narrative: Day 1-Fatigue; Day 2-Mild symptoms including fatigue, diarrhea, itching at injection site, headache, joint pain, muscle aches
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Day 1-Fatigue; Day 2-Mild symptoms including fatigue, diarrhea, itching at injection site, headache, joint pain, muscle aches
Age: 9.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site rash, Rash, Rash erythematous
Clinical narrative: Developed rash on upper arm about 24 hours after vaccine.  In area of injection and surrounding.  Rash is slightly raised, red, and bumpy.   Rest of arm is not swollen.  Applied cold compresses.  No MD visit.  Still has rash but is improving.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Hypertension
Clinical narrative: Patient received Pfizer vaccine booster at 09:06 am.  At 09:25 am while patient was being monitored she complained she had a headache.  Patient was moved to an exam bed  for monitoring  and V/S.  Initial v/s was  BP 147/83, P 70. Patient verbalized her blood pressure was high for her.  Her normal BP was 120/70.  Patient was awake , alert and oriented.  Patient later verbalized she felt dizzy.   BP repeated at 9:44 am noted at 144/77, P 69 sitting position. Standing position BP 142/75, P 68.   Patient was monitored for 30 minutes. At 9:52 am,  patient denies any further headache, dizziness, n/v,.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Incorrect Dose Moderna booster dose administered was 0.5 milliliters. Booster dose should have been 0.25 milliliters.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Condition aggravated, Dizziness, Fatigue, Injection site erythema
Clinical narrative: Chills, low grade fever, migraine, nausea, vomiting, aches all over body, redness and swelling at and around  injection site (?Covid arm?). Fatigue, lightheadedness, lasted about two days, then very tired for about a week.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Migraine, Nausea, Pain, Pyrexia
Clinical narrative: Chills, low grade fever, migraine, nausea, vomiting, aches all over body, redness and swelling at and around  injection site (?Covid arm?). Fatigue, lightheadedness, lasted about two days, then very tired for about a week.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Chills, low grade fever, migraine, nausea, vomiting, aches all over body, redness and swelling at and around  injection site (?Covid arm?). Fatigue, lightheadedness, lasted about two days, then very tired for about a week.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Incorrect Dose Moderna booster dose administered was 0.5 milliliters. Booster dose should have been 0.25 milliliters.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysmenorrhoea, Heavy menstrual bleeding, Ultrasound scan
Clinical narrative: significantly heavier and more painful (re: cramping) menstruation.  Starting August 2021 and observed to date.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test normal, Dysphagia, Influenza virus test negative, Lymphadenopathy, Oropharyngeal pain
Clinical narrative: First thing I noticed were body aches, second thing I noticed was a sore throat causing trouble swallowing, third thing I noticed was a fever starting at around 99 but increasing to 102. My glands on my neck were very swollen. This went on until about 11/27.  I went to the doctor first on 11/23 and received a flu, COVID and strep tests. On 11/24 I went to see my endocrinologist because I wanted bloodwork done.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, SARS-CoV-2 test negative, Streptococcus test negative
Clinical narrative: First thing I noticed were body aches, second thing I noticed was a sore throat causing trouble swallowing, third thing I noticed was a fever starting at around 99 but increasing to 102. My glands on my neck were very swollen. This went on until about 11/27.  I went to the doctor first on 11/23 and received a flu, COVID and strep tests. On 11/24 I went to see my endocrinologist because I wanted bloodwork done.
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Blood test, Blood thyroid stimulating hormone normal, Body temperature increased, Feeling jittery
Clinical narrative: pts mother stated his mouth became numb like he went to the dentist.  He became jittery, had stomach pain with a 102 temp.  A couple of weeks later he developed a sore throat that was a lump on the inside of his throat.  He saw his doctor in October.  He had blood work and was tested for thyroid disease that was negative so now will have to have a US that is scheduled for tomorrow.  Pt still has stomach pain.
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Oropharyngeal pain, Sensation of foreign body, Ultrasound scan
Clinical narrative: pts mother stated his mouth became numb like he went to the dentist.  He became jittery, had stomach pain with a 102 temp.  A couple of weeks later he developed a sore throat that was a lump on the inside of his throat.  He saw his doctor in October.  He had blood work and was tested for thyroid disease that was negative so now will have to have a US that is scheduled for tomorrow.  Pt still has stomach pain.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea
Clinical narrative: Severe chest pain and difficulty breathing, Thought I was having a heart attack. Happened 5 or 6 times over several weeks after the vaccine. Don?t know if I have permanent heart damage (checking none of the above for item 21 since I don?t know)
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Diabetic ketoacidosis, Fatigue, Hypoxia, Nausea
Clinical narrative: Pt was having generalized fatigue and nausea and vomiting.  She is admitted due to COVID pneumonia, DKA, and increased hypoxia.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Pt was having generalized fatigue and nausea and vomiting.  She is admitted due to COVID pneumonia, DKA, and increased hypoxia.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Acute respiratory failure, Asthenia, Atrial fibrillation, Bilirubin conjugated increased
Clinical narrative: a 77 year old male with a PMH of COPD (3L at home) dementia, urinary retention, neurogenic bowel disorder, and depression that presented to the ED on 10/9/21 with complaints of generalized weakness and altered mental status. Patient also endorsed urinary frequency/urgency, abdominal pain, intense headache, chills, and temperature increase from 96.7-99.7. When in the ED patient's temperature was 99.4. Labs were remarkable for:Total bilirubin of 1.3 (0.5 direct), sodium 129, chloride 96, bicarb 19, WBC 19.0 with left shift. CXR showed multifocal airway disease.  UA was not significant for signs of infection. While in the ED patient was started on vancomycin and cefepime. Urine culture was negative. Blood culture was 1/2 gram + bacilli in clusters, coagulase negative. Patient was placed on Azithromycin and Vancomycin was discontinued. CT Abdomen and Pelvis showed no acute process. KUB showed showed no bowel obstruction. Pulmonology was consulted for the patient's pneumonia and recommended 2D echo and follow up. Psychiatry was consulted for the patient's depression and recommended outpatient follow up. Neurology was consulted and recommended the patient remain on Risperdal given depression history and follow up. PMR evaluated the patient and parkinsonism likely secondary to drug reaction, recommended the patient for IPR. Patient's insurance denied IPR after initial application, where his wife appealed and the patient was later accepted. Patient was transferred on 10/14/20.   Within the last 48 hours, patient demonstrated increased O2 needs, with new onset inspiratory wheezing, minimally alleviated with breathing treatments. Last night, patient demonstrating acute hypoxic respiratory failure, where he was on his baseline 4L NC, with SpO2 in low 80s. Patient was then transition to HHF, FiO2 65% with SpO2 92%. CXR reviewed on 10/25 with minimal improvement. EKG shows new onset Afib. Patient was then found to be COVID+ -- where he was transferred out of IPR to PCU. Night team spoke with family where patient's status was changed to NO CODE.   Patient examined this AM. Patient is much more alert and conscious in comparison to yesterday. Wife at bedside. Admits to improvement with SOB when transitioned. Denies any current CP, palpitations, N/V/D.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Blood bicarbonate decreased, Blood bilirubin increased, Blood chloride decreased, Blood culture positive, Blood sodium decreased
Clinical narrative: a 77 year old male with a PMH of COPD (3L at home) dementia, urinary retention, neurogenic bowel disorder, and depression that presented to the ED on 10/9/21 with complaints of generalized weakness and altered mental status. Patient also endorsed urinary frequency/urgency, abdominal pain, intense headache, chills, and temperature increase from 96.7-99.7. When in the ED patient's temperature was 99.4. Labs were remarkable for:Total bilirubin of 1.3 (0.5 direct), sodium 129, chloride 96, bicarb 19, WBC 19.0 with left shift. CXR showed multifocal airway disease.  UA was not significant for signs of infection. While in the ED patient was started on vancomycin and cefepime. Urine culture was negative. Blood culture was 1/2 gram + bacilli in clusters, coagulase negative. Patient was placed on Azithromycin and Vancomycin was discontinued. CT Abdomen and Pelvis showed no acute process. KUB showed showed no bowel obstruction. Pulmonology was consulted for the patient's pneumonia and recommended 2D echo and follow up. Psychiatry was consulted for the patient's depression and recommended outpatient follow up. Neurology was consulted and recommended the patient remain on Risperdal given depression history and follow up. PMR evaluated the patient and parkinsonism likely secondary to drug reaction, recommended the patient for IPR. Patient's insurance denied IPR after initial application, where his wife appealed and the patient was later accepted. Patient was transferred on 10/14/20.   Within the last 48 hours, patient demonstrated increased O2 needs, with new onset inspiratory wheezing, minimally alleviated with breathing treatments. Last night, patient demonstrating acute hypoxic respiratory failure, where he was on his baseline 4L NC, with SpO2 in low 80s. Patient was then transition to HHF, FiO2 65% with SpO2 92%. CXR reviewed on 10/25 with minimal improvement. EKG shows new onset Afib. Patient was then found to be COVID+ -- where he was transferred out of IPR to PCU. Night team spoke with family where patient's status was changed to NO CODE.   Patient examined this AM. Patient is much more alert and conscious in comparison to yesterday. Wife at bedside. Admits to improvement with SOB when transitioned. Denies any current CP, palpitations, N/V/D.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature increased, COVID-19, Chest X-ray abnormal, Chills, Computerised tomogram abdomen normal
Clinical narrative: a 77 year old male with a PMH of COPD (3L at home) dementia, urinary retention, neurogenic bowel disorder, and depression that presented to the ED on 10/9/21 with complaints of generalized weakness and altered mental status. Patient also endorsed urinary frequency/urgency, abdominal pain, intense headache, chills, and temperature increase from 96.7-99.7. When in the ED patient's temperature was 99.4. Labs were remarkable for:Total bilirubin of 1.3 (0.5 direct), sodium 129, chloride 96, bicarb 19, WBC 19.0 with left shift. CXR showed multifocal airway disease.  UA was not significant for signs of infection. While in the ED patient was started on vancomycin and cefepime. Urine culture was negative. Blood culture was 1/2 gram + bacilli in clusters, coagulase negative. Patient was placed on Azithromycin and Vancomycin was discontinued. CT Abdomen and Pelvis showed no acute process. KUB showed showed no bowel obstruction. Pulmonology was consulted for the patient's pneumonia and recommended 2D echo and follow up. Psychiatry was consulted for the patient's depression and recommended outpatient follow up. Neurology was consulted and recommended the patient remain on Risperdal given depression history and follow up. PMR evaluated the patient and parkinsonism likely secondary to drug reaction, recommended the patient for IPR. Patient's insurance denied IPR after initial application, where his wife appealed and the patient was later accepted. Patient was transferred on 10/14/20.   Within the last 48 hours, patient demonstrated increased O2 needs, with new onset inspiratory wheezing, minimally alleviated with breathing treatments. Last night, patient demonstrating acute hypoxic respiratory failure, where he was on his baseline 4L NC, with SpO2 in low 80s. Patient was then transition to HHF, FiO2 65% with SpO2 92%. CXR reviewed on 10/25 with minimal improvement. EKG shows new onset Afib. Patient was then found to be COVID+ -- where he was transferred out of IPR to PCU. Night team spoke with family where patient's status was changed to NO CODE.   Patient examined this AM. Patient is much more alert and conscious in comparison to yesterday. Wife at bedside. Admits to improvement with SOB when transitioned. Denies any current CP, palpitations, N/V/D.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Culture urine negative, Depression, Dyspnoea, Electrocardiogram abnormal
Clinical narrative: a 77 year old male with a PMH of COPD (3L at home) dementia, urinary retention, neurogenic bowel disorder, and depression that presented to the ED on 10/9/21 with complaints of generalized weakness and altered mental status. Patient also endorsed urinary frequency/urgency, abdominal pain, intense headache, chills, and temperature increase from 96.7-99.7. When in the ED patient's temperature was 99.4. Labs were remarkable for:Total bilirubin of 1.3 (0.5 direct), sodium 129, chloride 96, bicarb 19, WBC 19.0 with left shift. CXR showed multifocal airway disease.  UA was not significant for signs of infection. While in the ED patient was started on vancomycin and cefepime. Urine culture was negative. Blood culture was 1/2 gram + bacilli in clusters, coagulase negative. Patient was placed on Azithromycin and Vancomycin was discontinued. CT Abdomen and Pelvis showed no acute process. KUB showed showed no bowel obstruction. Pulmonology was consulted for the patient's pneumonia and recommended 2D echo and follow up. Psychiatry was consulted for the patient's depression and recommended outpatient follow up. Neurology was consulted and recommended the patient remain on Risperdal given depression history and follow up. PMR evaluated the patient and parkinsonism likely secondary to drug reaction, recommended the patient for IPR. Patient's insurance denied IPR after initial application, where his wife appealed and the patient was later accepted. Patient was transferred on 10/14/20.   Within the last 48 hours, patient demonstrated increased O2 needs, with new onset inspiratory wheezing, minimally alleviated with breathing treatments. Last night, patient demonstrating acute hypoxic respiratory failure, where he was on his baseline 4L NC, with SpO2 in low 80s. Patient was then transition to HHF, FiO2 65% with SpO2 92%. CXR reviewed on 10/25 with minimal improvement. EKG shows new onset Afib. Patient was then found to be COVID+ -- where he was transferred out of IPR to PCU. Night team spoke with family where patient's status was changed to NO CODE.   Patient examined this AM. Patient is much more alert and conscious in comparison to yesterday. Wife at bedside. Admits to improvement with SOB when transitioned. Denies any current CP, palpitations, N/V/D.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Enzyme level test, Headache, Intensive care, Mental status changes, Micturition urgency
Clinical narrative: a 77 year old male with a PMH of COPD (3L at home) dementia, urinary retention, neurogenic bowel disorder, and depression that presented to the ED on 10/9/21 with complaints of generalized weakness and altered mental status. Patient also endorsed urinary frequency/urgency, abdominal pain, intense headache, chills, and temperature increase from 96.7-99.7. When in the ED patient's temperature was 99.4. Labs were remarkable for:Total bilirubin of 1.3 (0.5 direct), sodium 129, chloride 96, bicarb 19, WBC 19.0 with left shift. CXR showed multifocal airway disease.  UA was not significant for signs of infection. While in the ED patient was started on vancomycin and cefepime. Urine culture was negative. Blood culture was 1/2 gram + bacilli in clusters, coagulase negative. Patient was placed on Azithromycin and Vancomycin was discontinued. CT Abdomen and Pelvis showed no acute process. KUB showed showed no bowel obstruction. Pulmonology was consulted for the patient's pneumonia and recommended 2D echo and follow up. Psychiatry was consulted for the patient's depression and recommended outpatient follow up. Neurology was consulted and recommended the patient remain on Risperdal given depression history and follow up. PMR evaluated the patient and parkinsonism likely secondary to drug reaction, recommended the patient for IPR. Patient's insurance denied IPR after initial application, where his wife appealed and the patient was later accepted. Patient was transferred on 10/14/20.   Within the last 48 hours, patient demonstrated increased O2 needs, with new onset inspiratory wheezing, minimally alleviated with breathing treatments. Last night, patient demonstrating acute hypoxic respiratory failure, where he was on his baseline 4L NC, with SpO2 in low 80s. Patient was then transition to HHF, FiO2 65% with SpO2 92%. CXR reviewed on 10/25 with minimal improvement. EKG shows new onset Afib. Patient was then found to be COVID+ -- where he was transferred out of IPR to PCU. Night team spoke with family where patient's status was changed to NO CODE.   Patient examined this AM. Patient is much more alert and conscious in comparison to yesterday. Wife at bedside. Admits to improvement with SOB when transitioned. Denies any current CP, palpitations, N/V/D.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Parkinsonism, Pneumonia, Pollakiuria, Respiratory disorder, SARS-CoV-2 test positive
Clinical narrative: a 77 year old male with a PMH of COPD (3L at home) dementia, urinary retention, neurogenic bowel disorder, and depression that presented to the ED on 10/9/21 with complaints of generalized weakness and altered mental status. Patient also endorsed urinary frequency/urgency, abdominal pain, intense headache, chills, and temperature increase from 96.7-99.7. When in the ED patient's temperature was 99.4. Labs were remarkable for:Total bilirubin of 1.3 (0.5 direct), sodium 129, chloride 96, bicarb 19, WBC 19.0 with left shift. CXR showed multifocal airway disease.  UA was not significant for signs of infection. While in the ED patient was started on vancomycin and cefepime. Urine culture was negative. Blood culture was 1/2 gram + bacilli in clusters, coagulase negative. Patient was placed on Azithromycin and Vancomycin was discontinued. CT Abdomen and Pelvis showed no acute process. KUB showed showed no bowel obstruction. Pulmonology was consulted for the patient's pneumonia and recommended 2D echo and follow up. Psychiatry was consulted for the patient's depression and recommended outpatient follow up. Neurology was consulted and recommended the patient remain on Risperdal given depression history and follow up. PMR evaluated the patient and parkinsonism likely secondary to drug reaction, recommended the patient for IPR. Patient's insurance denied IPR after initial application, where his wife appealed and the patient was later accepted. Patient was transferred on 10/14/20.   Within the last 48 hours, patient demonstrated increased O2 needs, with new onset inspiratory wheezing, minimally alleviated with breathing treatments. Last night, patient demonstrating acute hypoxic respiratory failure, where he was on his baseline 4L NC, with SpO2 in low 80s. Patient was then transition to HHF, FiO2 65% with SpO2 92%. CXR reviewed on 10/25 with minimal improvement. EKG shows new onset Afib. Patient was then found to be COVID+ -- where he was transferred out of IPR to PCU. Night team spoke with family where patient's status was changed to NO CODE.   Patient examined this AM. Patient is much more alert and conscious in comparison to yesterday. Wife at bedside. Admits to improvement with SOB when transitioned. Denies any current CP, palpitations, N/V/D.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Shift to the left, Urinary system X-ray, Urine analysis normal, Wheezing, White blood cell count increased
Clinical narrative: a 77 year old male with a PMH of COPD (3L at home) dementia, urinary retention, neurogenic bowel disorder, and depression that presented to the ED on 10/9/21 with complaints of generalized weakness and altered mental status. Patient also endorsed urinary frequency/urgency, abdominal pain, intense headache, chills, and temperature increase from 96.7-99.7. When in the ED patient's temperature was 99.4. Labs were remarkable for:Total bilirubin of 1.3 (0.5 direct), sodium 129, chloride 96, bicarb 19, WBC 19.0 with left shift. CXR showed multifocal airway disease.  UA was not significant for signs of infection. While in the ED patient was started on vancomycin and cefepime. Urine culture was negative. Blood culture was 1/2 gram + bacilli in clusters, coagulase negative. Patient was placed on Azithromycin and Vancomycin was discontinued. CT Abdomen and Pelvis showed no acute process. KUB showed showed no bowel obstruction. Pulmonology was consulted for the patient's pneumonia and recommended 2D echo and follow up. Psychiatry was consulted for the patient's depression and recommended outpatient follow up. Neurology was consulted and recommended the patient remain on Risperdal given depression history and follow up. PMR evaluated the patient and parkinsonism likely secondary to drug reaction, recommended the patient for IPR. Patient's insurance denied IPR after initial application, where his wife appealed and the patient was later accepted. Patient was transferred on 10/14/20.   Within the last 48 hours, patient demonstrated increased O2 needs, with new onset inspiratory wheezing, minimally alleviated with breathing treatments. Last night, patient demonstrating acute hypoxic respiratory failure, where he was on his baseline 4L NC, with SpO2 in low 80s. Patient was then transition to HHF, FiO2 65% with SpO2 92%. CXR reviewed on 10/25 with minimal improvement. EKG shows new onset Afib. Patient was then found to be COVID+ -- where he was transferred out of IPR to PCU. Night team spoke with family where patient's status was changed to NO CODE.   Patient examined this AM. Patient is much more alert and conscious in comparison to yesterday. Wife at bedside. Admits to improvement with SOB when transitioned. Denies any current CP, palpitations, N/V/D.
Age: 4.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: No adverse effects. Vaccine was given before child was 5 years old. She received a second dose on 12/2/2021 before this was noticed. Parents gave us a birthdate at both appointments which would have made her 5 years old for both vaccines. Error was detected by in database.
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Lymphadenopathy, Pain in extremity, Pruritus, Pyrexia
Clinical narrative: Severe L arm pain, fever, and L-sided neck lymph node swelling x 2 days following injection. Then fever and neck swelling subsided No visible injection site reaction Abdominal itching since injection, but no rash. L arm pain lingering > 2 weeks after injection
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation
Clinical narrative: Burning sensation on the inside of my right thigh near knee. It comes and goes almost daily and several times of the day and night. No treatment offered.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, Dialysis, Exposure to SARS-CoV-2, Hypervolaemia
Clinical narrative: Case was hospitalized 9 months after completion of primary Covid vaccine series.  COVID-19 virus infection Assessment & Plan Diagnosed on 10/13. Lives at Facility and there was an outbreak there. Completed vaccine series in late January but it does not appear that he has received a booster (he is not certain). Hypoxic on arrival but some of this may have been from fluid overload. Received monoclonal antibodies at Facility on 10/13. Dexamethasone started on 10/15 after he became hypoxic. - Completed 10 day course of dexamethasone on 10/24 - Remdesivir contraindicated due to ESRD and LFT's >10x ULN - Tocilizumab given on 10/16 - Now back on room air - Off isolation after Nov 1  Acute respiratory failure with hypoxia  Assessment & Plan Secondary to fluid overload and Covid. Unclear what relative contribution was of each though given rapid improvement with dialysis volume overload may have been the bigger contributor. Resolved.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia, Liver function test, SARS-CoV-2 test positive
Clinical narrative: Case was hospitalized 9 months after completion of primary Covid vaccine series.  COVID-19 virus infection Assessment & Plan Diagnosed on 10/13. Lives at Facility and there was an outbreak there. Completed vaccine series in late January but it does not appear that he has received a booster (he is not certain). Hypoxic on arrival but some of this may have been from fluid overload. Received monoclonal antibodies at Facility on 10/13. Dexamethasone started on 10/15 after he became hypoxic. - Completed 10 day course of dexamethasone on 10/24 - Remdesivir contraindicated due to ESRD and LFT's >10x ULN - Tocilizumab given on 10/16 - Now back on room air - Off isolation after Nov 1  Acute respiratory failure with hypoxia  Assessment & Plan Secondary to fluid overload and Covid. Unclear what relative contribution was of each though given rapid improvement with dialysis volume overload may have been the bigger contributor. Resolved.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Incorrect dose administered
Clinical narrative: Incorrect Dose Moderna booster dose administered was 0.5 milliliters. Booster dose should have been 0.25 milliliters.
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Muscle spasms
Clinical narrative: Start around 2 hours after vaccine. The muscle was twisting. After 15 minutes, the twisting move throughout his body.  These symptoms lasted for about 36 hours. I took to him to the clinic on Monday morning. They did blood work on him. She did a physical exam for neuralgic exam.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Covid positive contact unknown
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: FF2593 Vial specified that expiration date was 11/2021. The pharmacy notified team that vial was expired 11/24/21. The vaccine was administered 11/29/21.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Incorrect Dose Moderna booster dose administered was 0.5 milliliters. Booster dose should have been 0.25 milliliters.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Cough, Decreased appetite, Dizziness
Clinical narrative: About 21 hours after my injection of my second dose of the Moderna Vaccine, I started having chills and uncontrollable shakes.  I left work and went home.  By about 5 pm, I was feeling weaker and felt like I was running a light fever.  I continued to have chills and uncontrollable shaking, at times.  by 6-7 pm, I felt like I had COVID all over again.  Very weak, shortness of breath, shaking, fever, aches, headache and loss of apatite.  This lasted and got worse through out the night.  The next day, I was still feeling the same.  Around noon time, I started developing a cough, like I had during my COVID experience back in August.  The doctor then told me I had a case of pneumonia with my COVID.  This felt the same.  I was incapacitated as far as doing normal activities.  I was still not eating and I could tell I was getting dehydrated.  By that evening, on the second day, I did finally start feeling better.  I got to a point were I could eat and drink, but still very tired, coughing and headaches.   The chills and fever had passed.  The third day, I was still weak, but not as bad, still having a headache and now I was a little dizzy.  I left work early on the first day and stayed home afterwards.  At the time of this writing, I am much better with a mild dull headache.  I am eating and drinking now, but still have a cough.  If the cough continues, I will seek medical care, but I hope it will clear up.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Headache, Pain, Pyrexia
Clinical narrative: About 21 hours after my injection of my second dose of the Moderna Vaccine, I started having chills and uncontrollable shakes.  I left work and went home.  By about 5 pm, I was feeling weaker and felt like I was running a light fever.  I continued to have chills and uncontrollable shaking, at times.  by 6-7 pm, I felt like I had COVID all over again.  Very weak, shortness of breath, shaking, fever, aches, headache and loss of apatite.  This lasted and got worse through out the night.  The next day, I was still feeling the same.  Around noon time, I started developing a cough, like I had during my COVID experience back in August.  The doctor then told me I had a case of pneumonia with my COVID.  This felt the same.  I was incapacitated as far as doing normal activities.  I was still not eating and I could tell I was getting dehydrated.  By that evening, on the second day, I did finally start feeling better.  I got to a point were I could eat and drink, but still very tired, coughing and headaches.   The chills and fever had passed.  The third day, I was still weak, but not as bad, still having a headache and now I was a little dizzy.  I left work early on the first day and stayed home afterwards.  At the time of this writing, I am much better with a mild dull headache.  I am eating and drinking now, but still have a cough.  If the cough continues, I will seek medical care, but I hope it will clear up.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: About 21 hours after my injection of my second dose of the Moderna Vaccine, I started having chills and uncontrollable shakes.  I left work and went home.  By about 5 pm, I was feeling weaker and felt like I was running a light fever.  I continued to have chills and uncontrollable shaking, at times.  by 6-7 pm, I felt like I had COVID all over again.  Very weak, shortness of breath, shaking, fever, aches, headache and loss of apatite.  This lasted and got worse through out the night.  The next day, I was still feeling the same.  Around noon time, I started developing a cough, like I had during my COVID experience back in August.  The doctor then told me I had a case of pneumonia with my COVID.  This felt the same.  I was incapacitated as far as doing normal activities.  I was still not eating and I could tell I was getting dehydrated.  By that evening, on the second day, I did finally start feeling better.  I got to a point were I could eat and drink, but still very tired, coughing and headaches.   The chills and fever had passed.  The third day, I was still weak, but not as bad, still having a headache and now I was a little dizzy.  I left work early on the first day and stayed home afterwards.  At the time of this writing, I am much better with a mild dull headache.  I am eating and drinking now, but still have a cough.  If the cough continues, I will seek medical care, but I hope it will clear up.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling, Pruritus
Clinical narrative: VACCINE WAS RECEIVED AT THE PHARMACY IN EARLY AFTERNOON AT THE PHARMACY.  APPROXIMATELY 9PM SHE STARTED TO EXPERIENCE LIPS SWELLING AND ITCHING SKIN.  TREATED WITH BENADRYL 50MG [2 X 25MG CAPSULES] AND REPEATED AT 2AM.  REACTION SUBSIDED BY 3AM.  PATIENT REFUSED TO USE EPI PEN [WHICH SHE HAS A PRESCRIPTION] AND REFUSED TO GO TO EMERGENCY ROOM.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, Anticoagulant therapy, Arteriosclerosis coronary artery, Asthenia, Brain natriuretic peptide increased
Clinical narrative: Hospitalized 11/29/2021-still admitted currently; COVID-19 positive 11/24/21; fully vaccinated  ASSESSMENT Principal Problem:   Pneumonia due to COVID-19 virus Active Problems:   Emphysema   OSA (obstructive sleep apnea)   Type 2 diabetes mellitus with hyperglycemia, with long-term current use of insulin   Dyslipidemia   Essential hypertension   Depression with anxiety   History of ITP   Rheumatoid arthritis   Acute respiratory failure with hypoxia   Chronic, continuous use of opioids   Coronary artery disease involving native coronary artery of native heart without angina pectoris   Chronic diastolic heart failure  PLAN Cont O2 support, wean as able; currently on 2L Day of illness: 5 Cont Decadron x 10 days total Remdesivir - multiple high risk factors Cont other supportive measures CXR - no significant infiltrates Still at high risk of worsening as she reaches day 7 to 10 of illness 12/2/2021 note: Acute hypoxic respiratory failure-secondary to Covid infection vs COPD Sx start 11/24/21: weakness, fatigue, diarrhea, cough Covid + 11/24/21 CRP: 15 D-dimer: 950 BNP 370 CXR: no acute abnormalities Will cont remdesivir and decadron  Lovenox for DVT ppx Will continue supplemental oxygen to maintain SaO2>90% Cont mucinex and tessalon pearls The patient is on 1 L NC  Dispo: Will monitor respiratory status. Improvement in kidney function. PT/OT. Likely dc home in 2-3 days.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: C-reactive protein increased, COVID-19, COVID-19 pneumonia, Chest X-ray normal, Chronic left ventricular failure
Clinical narrative: Hospitalized 11/29/2021-still admitted currently; COVID-19 positive 11/24/21; fully vaccinated  ASSESSMENT Principal Problem:   Pneumonia due to COVID-19 virus Active Problems:   Emphysema   OSA (obstructive sleep apnea)   Type 2 diabetes mellitus with hyperglycemia, with long-term current use of insulin   Dyslipidemia   Essential hypertension   Depression with anxiety   History of ITP   Rheumatoid arthritis   Acute respiratory failure with hypoxia   Chronic, continuous use of opioids   Coronary artery disease involving native coronary artery of native heart without angina pectoris   Chronic diastolic heart failure  PLAN Cont O2 support, wean as able; currently on 2L Day of illness: 5 Cont Decadron x 10 days total Remdesivir - multiple high risk factors Cont other supportive measures CXR - no significant infiltrates Still at high risk of worsening as she reaches day 7 to 10 of illness 12/2/2021 note: Acute hypoxic respiratory failure-secondary to Covid infection vs COPD Sx start 11/24/21: weakness, fatigue, diarrhea, cough Covid + 11/24/21 CRP: 15 D-dimer: 950 BNP 370 CXR: no acute abnormalities Will cont remdesivir and decadron  Lovenox for DVT ppx Will continue supplemental oxygen to maintain SaO2>90% Cont mucinex and tessalon pearls The patient is on 1 L NC  Dispo: Will monitor respiratory status. Improvement in kidney function. PT/OT. Likely dc home in 2-3 days.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chronic obstructive pulmonary disease, Cough, Depression, Diarrhoea, Drug use disorder
Clinical narrative: Hospitalized 11/29/2021-still admitted currently; COVID-19 positive 11/24/21; fully vaccinated  ASSESSMENT Principal Problem:   Pneumonia due to COVID-19 virus Active Problems:   Emphysema   OSA (obstructive sleep apnea)   Type 2 diabetes mellitus with hyperglycemia, with long-term current use of insulin   Dyslipidemia   Essential hypertension   Depression with anxiety   History of ITP   Rheumatoid arthritis   Acute respiratory failure with hypoxia   Chronic, continuous use of opioids   Coronary artery disease involving native coronary artery of native heart without angina pectoris   Chronic diastolic heart failure  PLAN Cont O2 support, wean as able; currently on 2L Day of illness: 5 Cont Decadron x 10 days total Remdesivir - multiple high risk factors Cont other supportive measures CXR - no significant infiltrates Still at high risk of worsening as she reaches day 7 to 10 of illness 12/2/2021 note: Acute hypoxic respiratory failure-secondary to Covid infection vs COPD Sx start 11/24/21: weakness, fatigue, diarrhea, cough Covid + 11/24/21 CRP: 15 D-dimer: 950 BNP 370 CXR: no acute abnormalities Will cont remdesivir and decadron  Lovenox for DVT ppx Will continue supplemental oxygen to maintain SaO2>90% Cont mucinex and tessalon pearls The patient is on 1 L NC  Dispo: Will monitor respiratory status. Improvement in kidney function. PT/OT. Likely dc home in 2-3 days.